Literature DB >> 10563765

Cellular uptake of adamantyl conjugated peptide nucleic acids.

T Ljungstrøm1, H Knudsen, P E Nielsen.   

Abstract

Peptide nucleic acids (PNA) (15-mers) conjugated to adamantyl acetic acid and labeled with fluorescein have been prepared, and their (liposome mediated) uptake in human cells in culture (HeLa, IMR-90 and MDA-MB-453) has been studied by confocal fluorescence microscopy. It is found that adamantyl-PNAs show greatly improved (endosomal) cellular uptake, but that this uptake is dependent on the cell line. Cellular uptake of such lipophilic PNAs is further mediated by cationic liposomes, and in some cases, the intracellular localization is diffuse cytoplasmic or nuclear, again cell-type dependent. The results show that this simple PNA modification can indeed greatly improve cellular uptake, but the effect appears strongly cell-type as well as PNA-sequence dependent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10563765     DOI: 10.1021/bc990053+

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  12 in total

Review 1.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

2.  Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease.

Authors:  A Muratovska; R N Lightowlers; R W Taylor; D M Turnbull; R A Smith; J A Wilce; S W Martin; M P Murphy
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

3.  Destabilization of tRNA3(Lys) from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog.

Authors:  N Kaushik; T T Talele; R Monel; P Palumbo; V N Pandey
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

4.  Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production.

Authors:  Neerja Kaushik; Amartya Basu; Paul Palumbo; Rene L Myers; Virendra N Pandey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 5.  Nanotechnology for delivery of peptide nucleic acids (PNAs).

Authors:  Anisha Gupta; Raman Bahal; Meera Gupta; Peter M Glazer; W Mark Saltzman
Journal:  J Control Release       Date:  2016-01-08       Impact factor: 9.776

6.  Down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine-PNA (peptide nucleic acid) conjugates.

Authors:  Takehiko Shiraishi; Peter E Nielsen
Journal:  Nucleic Acids Res       Date:  2004-09-15       Impact factor: 16.971

7.  Synthesis, characterization, and evaluation of a novel 99mTc(CO)3 pyrazolyl conjugate of a peptide nucleic acid sequence.

Authors:  Catarina Xavier; Clelia Giannini; Sergio Dall'Angelo; Lurdes Gano; Stefano Maiorana; Roger Alberto; Isabel Santos
Journal:  J Biol Inorg Chem       Date:  2008-09-06       Impact factor: 3.358

8.  Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element.

Authors:  Sabyasachi Ganguly; Binay Chaubey; Snehlata Tripathi; Alok Upadhyay; Prasad V S V Neti; Roger W Howell; Virendra Nath Pandey
Journal:  Oligonucleotides       Date:  2008-09

9.  Cell number and transfection volume dependent peptide nucleic acid antisense activity by cationic delivery methods.

Authors:  Laia Llovera; Peter Berthold; Peter E Nielsen; Takehiko Shiraishi
Journal:  Artif DNA PNA XNA       Date:  2012 Jan-Mar

10.  Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells.

Authors:  Takehiko Shiraishi; Ramin Hamzavi; Peter E Nielsen
Journal:  Nucleic Acids Res       Date:  2008-07-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.